---
document_datetime: 2025-11-27 14:05:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lynkuet-epar-all-authorised-presentations_en.pdf
document_name: lynkuet-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7753965
conversion_datetime: 2025-12-27 19:31:19.189836
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging                | Pack size                                         |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------------------|---------------------------------------------------|
| EU/1/25/1991/001 | Lynkuet           | 60 mg      | Capsule, soft         | Oral use                  | blister (PVC/PCTFE- alu/PET/paper) | 12 × 2 capsules (unit dose)                       |
| EU/1/25/1991/002 | Lynkuet           | 60 mg      | Capsule, soft         | Oral use                  | blister (PVC/PCTFE- alu/PET/paper) | 30 × 2 capsules (unit dose)                       |
| EU/1/25/1991/003 | Lynkuet           | 60 mg      | Capsule, soft         | Oral use                  | blister (PVC/PCTFE- alu/PET/paper) | 180 (3 × 30 × 2) capsules (unit dose) (multipack) |